Arousal Gels: Marketing vs Evidence
SaveDrugstore arousal and warming gels have thin evidence of working; the tingle they create comes from irritant ingredients like menthol and capsaicin, not improved arousal [1]. Roughly 4 in 10 women report a sexual concern at some point, and warming additives can sting sensitive tissue. Plain lubricants are usually gentler and better studied.
Last updated: July 2026
Continue in Claude
Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.
The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.
What are arousal and warming gels supposed to do?
Arousal gels are topical products that promise faster or stronger arousal, usually through a tingling or warming sensation. Common ingredients include menthol, L-arginine, capsaicin, cinnamon, and assorted botanicals, and many are simply flavored or 'stimulating' lubricants. The sensation they create is real, since menthol and capsaicin genuinely irritate nerve endings, but a tingle is not the same as improved arousal or desire. According to the American College of Obstetricians and Gynecologists, arousal is complex and shaped by blood flow, hormones, mood, and stimulation, so a surface gel addresses only a sliver of it 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Roughly 4 in 10 women report a sexual concern at some point 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy..
Do arousal gels actually work?
Rigorous evidence that over-the-counter arousal gels improve sexual response is scarce. Most marketing rests on the physical sensation of warming or tingling, small company-run surveys, or 'clinically tested' claims that were never published as controlled trials 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. The interventions with real evidence are different: for menopausal women, hormone therapy modestly improves lubrication and sexual function in controlled studies over about 12 weeks 4Ref 4Nastri CO, Lara LA, Ferriani RA, et al. (2013).Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls., and plain lubricants reliably reduce friction. A warming additive, by contrast, can backfire, because the same capsaicin or menthol that tingles can also sting inflamed or dry tissue. Distressing low arousal or desire affects roughly 1 in 10 women and rarely responds to a drugstore gel 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy..
Can arousal gels irritate or harm?
Warming and 'stimulating' gels are among the more irritating products on the shelf. Ingredients meant to create heat or tingling can cause burning, swelling, or micro-irritation, especially on tissue that is already dry or sensitive. Irritation can also mimic infection: a yeast infection or bacterial vaginosis causes overlapping itching and discharge, and MedlinePlus notes that new irritation with discharge or odor deserves evaluation rather than another product 3Ref 3MedlinePlus (National Library of Medicine) (2024).Vaginitis.MedlinePlus overview of vaginitis: new irritation with discharge or odor warrants evaluation, and yeast infections are extremely common, affecting about three in four women at least once.. People with vaginal dryness or genitourinary changes are especially prone to stinging, so a plain, low-additive lubricant is usually the gentler choice. Fragrance and glycerin add further irritation risk.
What helps arousal more than a gel?
Arousal responds better to addressing its underlying drivers, which ACOG recommends evaluating before any product 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Adequate lubrication, unhurried stimulation, managing pain, treating dryness, and reviewing medications that dull response all do more than a warming gel. When low sex drive or arousal difficulty is persistent and distressing, a clinician can look for treatable causes. Arousal and lubrication also shift across life stages: falling estrogen in the perimenopausal transition and the postpartum months lengthens the time to arousal and reduces natural wetness, which vaginal estrogen or moisturizers can ease 2Ref 2Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.. A gel does not touch those root causes.
When low arousal is worth a clinician visit
Arousal or lubrication problems that persist and bother you are worth a clinician's evaluation instead of a shelf of gels. A gynecologist or primary care clinician can check for dryness, hormonal shifts, medication effects, pain conditions, and relationship or mood factors, then suggest options with actual evidence 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.2Ref 2Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.. Over-the-counter arousal products are low-stakes to try, but they are not a substitute for that workup when the problem is ongoing. A brief visit can point you toward what genuinely helps rather than what simply tingles.
Common questions
Related
Sexual health
Libido Supplements: What's Actually in ThemSexual health
Testosterone for Low Desire: What Evidence SupportsSexual health
Vyleesi (Bremelanotide): An On-Demand Option
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When arousal problems deserve a closer look
- —Burning, swelling, or a rash after using a gel is a reason to stop the product and seek clinician review
- —New irritation with discharge or odor is a reason to seek clinician review for possible infection
- —Pain or arousal difficulty that persists and distresses you is a reason to seek clinician evaluation
- —Arousal changes alongside new medications or menopausal symptoms are a reason to discuss options with a clinician
This article is general health education, not medical advice. Whether a product or treatment fits your situation is best decided with a gynecologist or primary care clinician who knows your history.
References
- 1.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003324 ✓ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.
- 2.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.
- 3.MedlinePlus (National Library of Medicine) (2024). Vaginitis. MedlinePlus, U.S. National Library of Medicine (NIH). link ✓MedlinePlus overview of vaginitis: new irritation with discharge or odor warrants evaluation, and yeast infections are extremely common, affecting about three in four women at least once.
- 4.Nastri CO, Lara LA, Ferriani RA, et al. (2013). Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009672.pub2 ✓Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls.
4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy